AGP Executive Report
Last update: 10 hours agoMacao Healthcare Spotlight: The Macao Union Medical Center (Peking Union Medical College Hospital) kicked off its 2nd anniversary celebration and Medical and Health Forum, with senior SAR and mainland health officials attending—an upbeat sign for local medical services and cross-sector health dialogue. Cardiometabolic Drug Watch: Novo Nordisk struck a licensing deal with China’s Hengrui Pharma for HRS-1596, a Phase 1-ready oral GLP-1/GIP dual agonist with potential once-weekly dosing; the agreement could reach up to US$2.6bn (US$300m upfront) and excludes mainland China, Hong Kong, Macao and Taiwan. Heart Health Reminder: On World Heart Day, Hong Kong’s Department of Health urged the public to adopt heart-healthy habits—balanced diet, physical activity, and avoiding smoking and drinking—while using prevention programmes to cut cardiovascular disease risk. Public Health Alerts: Hong Kong’s Centre for Health Protection reported four new Legionnaires’ disease cases (Sept 20–26) and reminded higher-risk groups to follow water-system precautions. Community & Wellness: A Macau survey found 36.2% of residents volunteered in the past year, with participation highest among young adults and seniors—highlighting social support as part of wellbeing. Health Tech & Safety: TrendAI expanded support for Claude’s Compliance API in TrendAI Vision One™, letting security teams investigate AI agent activity tied to verified users.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
